SCHEMBL21628405

SCHEMBL21628405

O=C(O)c1cnc(Oc2ccc(C3CCC3)cc2)c(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 4/20 0.42
ALOX5AP P20292 3/20 0.42
MRGPRX4 Q96LA9 1/20 0.42
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GLA P06280 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PTGER4 P35408 5/20 0.38
KMO O15229 1/20 0.38
HAO1 Q9UJM8 1/20 0.37
PARP10 Q53GL7 1/20 0.37
HCAR3 P49019 1/20 0.36
PTGER2 P43116 1/20 0.36
DHODH Q02127 1/20 0.36
PPARG P37231 1/20 0.36
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21628737 0.98 KMT2A (0.43) FEN1ALOX5APMRGPRX4KMT2AKDM4E
SCHEMBL20482060 0.96 KMT2A (0.45) FEN1ALOX5APMRGPRX4KMT2AKDM4E
SCHEMBL21628889 0.96 KMT2A (0.45) FEN1ALOX5APMRGPRX4KMT2AKDM4E
SCHEMBL21628617 0.95 MRGPRX4 (0.46) FEN1ALOX5APMRGPRX4PTGER4PARP10
SCHEMBL21628753 0.89 PARP10 (0.46) FEN1ALOX5APPARP10
SCHEMBL21628664 0.87 HDAC6 (0.49)
SCHEMBL21628393 0.87 ALOX5AP (0.45) FEN1ALOX5APSMN1; SMN2HAO1
SCHEMBL21628434 0.87 PARP10 (0.46) FEN1ALOX5APHAO1PARP10
SCHEMBL21628743 0.86 ALDH1A1 (0.40) FEN1ALOX5APSMN1; SMN2HAO1PARP10
SCHEMBL21628418 0.86 PARP10 (0.45) FEN1ALOX5APKMT2AKDM4EGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600696-B2 Aromatic compounds Xeniopro GmbH (DE) 2026-04-14 US disclosed
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-12-21 US disclosed
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2023-05-18 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-11591289-B2 Aromatic compounds Xeniopro GmbH (DE) 2023-02-28 US disclosed
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2022-11-03 US disclosed
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2021-04-15 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS Xeniopro GmbH (DE) 2020-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230150923-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK FEN1 4361/4885ALOX5AP 3143/4885MRGPRX4 1318/4885
US-20220348535-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK FEN1 4361/4885ALOX5AP 3143/4885MRGPRX4 1318/4885
US-11591289-B2 Aromatic compounds AHR, TYR, MUSK FEN1 4128/4885ALOX5AP 3337/4885MRGPRX4 1698/4885
US-20210107863-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK FEN1 4361/4885ALOX5AP 3143/4885MRGPRX4 1318/4885
US-12600696-B2 Aromatic compounds CCR1, CCRL2, AHR FEN1 1122/4885ALOX5AP 3839/4885MRGPRX4 1888/4885
US-20230406814-A2 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK FEN1 4361/4885ALOX5AP 3143/4885MRGPRX4 1318/4885
US-20200031763-A1 NOVEL AROMATIC COMPOUNDS AHR, TYR, MUSK FEN1 4361/4885ALOX5AP 3143/4885MRGPRX4 1318/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.